Remarkably , at peak immunogenicity , the concentration of anti-V@V@ IgG , a response associated with a reduced risk of HIV-@ acquisition in the RV@ adult vaccine trial , was @-fold higher in Chiron vaccine recipients , compared with RV@ vaccinees .